Hubert H. Fernandez, MD

Size: px
Start display at page:

Download "Hubert H. Fernandez, MD"

Transcription

1 Hubert H. Fernandez, MD Associate Professor Co-Director, Movement Disorders Center Director, Clinical Trials for Movement Disorders Program Director, Neurology Residency and Movement Disorders Fellowship Training Program University of Gainesville

2 Disclosures Hubert H. Fernandez, MD has, over the past 5 years, been a paid consultant, paid speaker or performed clinical research under contract with: Amarin, Allergan, AstraZeneca, Aventis, Boehringer Ingelheim, Boston Life Sciences, Biogen Idec, Cephalon, Easai, Elan, Forest Laboratories, GlaxoSmithKlein, Huntington Study Group, Ipsen, Kyowa, Merck KgaA, Merz, MylanBertek, National Parkinson Foundation, Neurotrax, NIH/NINDS, Novartis, Parkinson Study Group, Solstice, Solvay, Teva, United Biosource Corporation, Valeant, and Vernalis; but has no owner interest in any pharmaceutical company.

3 Common Indications for Botox Dystonia (ST, blepharospams,, focal and segmental) Hemi-facial spasms Spasticity Headache Wrinkles Drooling Gait freezing

4 Dystonia.is a neurologic syndrome characterized by involuntary, sustained, patterned, and often repetitive muscle contractions of opposing muscles causing twisting movements or abnormal postures. Partly because of its rich expression and a variable course, dystonia is frequently not recognized or misdiagnosed Fahn 1984.

5 Main features of dystonia relatively long duration (unlike chorea or myoclonus) simultaneous contractions of agonist and antagonist muscles results in twisting of a body part same muscle groups are generally involved

6 Other Features Primary dystonia almost always begins by affecting a single part of the body (focal dystonia); most often the spread is to contiguous body parts The younger the age at onset, the more likely for dystonia to spread Action dystonia: dystonic movement aggravated during voluntary movements Task specific dystonia: abnormal movement appear during special action Overflow: as dystonia progresses, non-specific voluntary action can bring out dystonia, also actions in other parts of the body can induce dystonic movements of the primarily affected body part Worsen with fatigue, stress; suppressed with sleep, hypnosis, relaxation Sensory tricks (geste( antagoniste) Pain is not very common except in cervical dystonia Can present with tremor (dystonic tremor) or myoclonus (dystonia-myoclonus)

7 Overflow Dystonia

8 Task Specific Dystonia

9 Sensory Trick

10 Classification By Age at Onset Early onset (<26 years) Late onset (>26 years) By Distribution Focal - single body region (e.g., writer s s cramp, torticollis, blepharospasm) Segmental - contiguous body regions (e.g., face+jaw [Meige s], neck+arm) Multifocal - non-contiguous body regions (e.g., arm+leg, bleph+writer s cramp) Generalized - both legs + at least one other body region (one or both arms) By Cause Primary (idiopathic) - dystonia is only sign in the absence of identifiable exogenous cause or other inherited or degenerative disease Secondary (symptomatic) Dystonia-plus (accompanied by parkinsonism or myoclonus) Heredodegenerative dystonia (X-linked, autosomal dominant or recessive) Acquired/exogenous (drugs, trauma, stroke) Parkinsonian syndromes (PD, CBGD, PSP)

11 Focal Dystonias Cervical dystonia (CD) or spasmodic torticollis Blepharospasm Laryngeal dystonia or spasmodic dysphonia (SD) Limb dystonia (writer s s or musician s s cramp, etc.)

12 Cervical Dystonia: idiopathic

13 Cervical dystonia: tardive

14 Cervical Dystonia: tardive

15 Blepharospasms

16 Apraxia of eyelid opening

17 Laryngeal Dystonia: adductor

18 Laryngeal Dystonia: abductor

19 Focal Limb Dystonia

20 Hemi-dystonia

21 Generalized Dystonia

22 Secondary Dystonia: Lubag

23 Secondary Dystonia: perinatal injury

24 Secondary Dystonia: Post Traumatic

25 Dystonia in CBGD

26 Dystonia in PD

27 Dystonia in PSP

28 Therapy Pharmacotherapy CNS active drugs Anticholinergics GABAergics (benzodiazepines, baclofen, tizanidine) Dopaminergics (DA agonists, DA antagonists, DA depletors) Other (carbamazepine, alcohol, lithium, cannabinoids) Local injections (Botulinum toxin) Physical and supportive therapy PT and orthopedic devices (bracing) Repetitive transcranial magnetic stimulation Patient and caregiver education and support Surgical therapy Peripheral denervation Central Ablative procedures (thalamotomy, pallidotomy) DBS

29 Botox for the face: Blepharospasms x x x x x x x x x x x x

30 Botox for headache Frontalis Temporalis Insertion of the SCM Occipitalis Upper Trapezius

31 Botox for Hemifacial Spasms x x x x x x

32 Jaw dystonia Jaw closing dystonia Masseter Temporalis Jaw opening dystonia Lateral pterygoids Digastric

33 Cervical Dystonia: : Which muscles to inject? Torticollis (chin deviation) Laterocollis (tilt) Anterocollis (neck flexion) Retrocollis (neck extension) Shoulder elevation Head tremor

34 Torticollis Contralateral SCM Ipsilateral splenius capitis Ipsilateral semispinalis capitis

35 Laterocollis Ipsilateral scalenes Ipsilateral levator scapulae Ipsilateral splenius capitis Ipsilateral SCM

36 Shoulder elevation Ipsilateral levator scapulae Ipsilateral upper trapezius

37 Anterocollis Bilateral SCM Bilateral anterior scalene Bilateral submentalis

38 Retrocollis Bilateral splenius capitis Bilateral trapezius Bilateral semispinalis capitis

39 Head tremor Main vs compensatory muscles 3 to 4: 1 dosing ratio

40 Structures to avoid Brachial plexus Carotid sheath Greater occipital nerve Larynx and trachea Pharynx and esophagus Thyroid gland Pleura and apex of the lung

41 Post-injection expectations 70% get about 60-80% improvement 3-44 months duration Side effects Dysphagia Pain Dry mouth Fatigue Secondary non- reponsiveness

42 Let s s do some exercises!

43 Example 1

44 Example 2

45 Example 3

46 Dosing Increase Low weight Small muscle bulk Mild disease High probability of weakness Too much weakness from previous injection Decrease Heavy weight Large muscle bulk Severe disease Low concern for weakness

47 Materials Needed 30G x ½ needle 27G x 1¼ 1 needle 21G x 2 2 needle 1 cc syringe Lidocaine 4% topical cream Preservative free normal saline

48 Thank you!

THE CLINICAL USE OF BOTULINUM TOXIN IN THE TREATMENT OF MOVEMENT DISORDERS, SPASTICITY, AND SOFT TISSUE PAIN

THE CLINICAL USE OF BOTULINUM TOXIN IN THE TREATMENT OF MOVEMENT DISORDERS, SPASTICITY, AND SOFT TISSUE PAIN THE CLINICAL USE OF BOTULINUM TOXIN IN THE TREATMENT OF MOVEMENT DISORDERS, SPASTICITY, AND SOFT TISSUE PAIN Spasmodic torticollis (cervical dystonia), blepharospasm, and writer s cramp are specific types

More information

Dystonia: Title. A real pain in the neck. in All the Wrong Places

Dystonia: Title. A real pain in the neck. in All the Wrong Places Focus on CME at the University of Western Ontario Dystonia: Title in All the Wrong Places A real pain in the neck By Mandar Jog, MD, FRCPC and; Mary Jenkins, MD, FRCPC What is dystonia? Dystonia is a neurologic

More information

Diagnosis and treatment of dystonia

Diagnosis and treatment of dystonia Diagnosis and treatment of dystonia Professor Tom Warner, Reta Lila Weston Institute of Neurological Studies UCL Institute of Neurology National Hospital for Neurology and Neurosurgery Queen Square What

More information

Treating Cervical Dystonia. Atul T. Patel, MD, MHSA Vice President, Kansas City Bone & Joint Clinic Overland Park, KS

Treating Cervical Dystonia. Atul T. Patel, MD, MHSA Vice President, Kansas City Bone & Joint Clinic Overland Park, KS Treating Cervical Dystonia Atul T. Patel, MD, MHSA Vice President, Kansas City Bone & Joint Clinic Overland Park, KS Disclosures Grant/Research support and Speaker s Bureau for Allegan plc, Merz Pharmaceuticals,

More information

Professor Tim Anderson

Professor Tim Anderson Professor Tim Anderson Neurologist University of Otago Christchurch 11:00-11:55 WS #91: Shakes Jerks and Spasms - Recognition and Differential Diagnosis 12:05-13:00 WS #102: Shakes Jerks and Spasms - Recognition

More information

Professor Tim Anderson

Professor Tim Anderson Professor Tim Anderson Neurologist University of Otago Christchurch 11:00-11:55 WS #91: Shakes Jerks and Spasms - Recognition and Differential Diagnosis 12:05-13:00 WS #102: Shakes Jerks and Spasms - Recognition

More information

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology Movement Disorders Will Garrett, M.D Assistant Professor of Neurology I. The Basal Ganglia The basal ganglia are composed of several structures including the caudate and putamen (collectively called the

More information

Diagnosis and treatment of dystonia

Diagnosis and treatment of dystonia Diagnosis and treatment of dystonia Professor Tom Warner, Reta Lila Weston Institute of Neurological Studies UCL Institute of Neurology National Hospital for Neurology and Neurosurgery Queen Square What

More information

Understanding Dystonia

Understanding Dystonia Understanding Dystonia Sand Sharks Anthony Richardsen, Lindsey Rathbun, Evan Harrington, Chris Erzen The Essentials What, Why, How What is Dystonia? Dystonias are movement disorders often characterized

More information

Botuli focal d THERAPEUTIC INTERVENTION

Botuli focal d THERAPEUTIC INTERVENTION 30 PRACTICAL NEUROLOGY THERAPEUTIC INTERVENTION The Little Milkmaid by Amedeo Modigliani (1884 1920). Does this represent artistic licence or cervical dystonia? Nigel Hyman Department of Neurology, Radcliffe

More information

GENETICS AND TREATMENT OF DYSTONIA

GENETICS AND TREATMENT OF DYSTONIA GENETICS AND TREATMENT OF DYSTONIA Oksana Suchowersky, M.D., FRCPC, FCCMG Professor of Medicine, Medical Genetics, and Psychiatry Toupin Research Chair in Neurology DYSTONIA Definition: abnormal sustained

More information

Parkinson's Disease Center and Movement Disorders Clinic

Parkinson's Disease Center and Movement Disorders Clinic Parkinson's Disease Center and Movement Disorders Clinic 7200 Cambridge Street, 9th Floor, Suite 9A Houston, Texas 77030 713-798-2273 phone www.jankovic.org Dystonia Diagnosis Dystonia is a neurologic

More information

This guide describes some of the important facts about Neurobloc that you need to be aware of, however, it does not replace the advice given to you

This guide describes some of the important facts about Neurobloc that you need to be aware of, however, it does not replace the advice given to you This guide describes some of the important facts about Neurobloc that you need to be aware of, however, it does not replace the advice given to you by a healthcare professional. Further very important

More information

Dr Barry Snow. Neurologist Auckland District Health Board

Dr Barry Snow. Neurologist Auckland District Health Board Dr Barry Snow Neurologist Auckland District Health Board Dystonia and Parkinson s disease Barry Snow Gowers 1888: Tetanoid chorea Dystonia a movement disorder characterized by sustained or intermittent

More information

Source: *Dystonia facts medically edited by: Charles Patrick Davis, MD, PhD

Source:  *Dystonia facts medically edited by: Charles Patrick Davis, MD, PhD Source: http://www.medicinenet.com/script/main/art.asp?articlekey=349 Dystonia facts* *Dystonia facts medically edited by: Charles Patrick Davis, MD, PhD Dystonia is a disorder of muscle control; it can

More information

Cervical Dystonia. One type of dystonia Julie Rope

Cervical Dystonia. One type of dystonia Julie Rope Cervical Dystonia One type of dystonia Julie Rope Cervical Dystonia Patterned, repetitive, and spasmodic or sustained muscle contractions resulting in abnormal movements and postures of the head and neck

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Xeomin) Reference Number: CP.PHAR.231 Effective Date: 07.01.16 Last Review Date 05.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: ERX.SPA.194 Effective Date:

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: ERX.SPA.194 Effective Date: Clinical Policy: (Xeomin) Reference Number: ERX.SPA.194 Effective Date: 01.11.17 Last Review Date: 11.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St. Movement Disorders- Parkinson s Disease Fahed Saada, MD March 8 th, 2019 48 th Family Medicine Refresher Course St. Joseph s Health Disclosure ACADIA Pharmaceuticals Objectives Review the classification

More information

Ms Anne Recordon. Physiotherapist Neuro Rehab Results Queenstown

Ms Anne Recordon. Physiotherapist Neuro Rehab Results Queenstown Ms Anne Recordon Physiotherapist Neuro Rehab Results Queenstown 14:00-14:55 WS #106: Managing Dystonia in Children and Adults 15:05-16:00 WS #117: Managing Dystonia in Children and Adults (Repeated) Dystonia

More information

Sensory Trick in Task Specific Upper Limb Dystonia (ULD)

Sensory Trick in Task Specific Upper Limb Dystonia (ULD) UNIVERSITÀ DEGLI STUDI DI CAGLIARI Dipartimento di Scienze Mediche e Sanità Pubblica Scuola di Specializzazione in Neurologia Direttore: Prof. Giovanni Defazio Sensory Trick in Task Specific Upper Limb

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Myobloc) Reference Number: CP.PHAR.233 Effective Date: 07.01.16 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Coding Implications Revision Log See Important Reminder

More information

Medication Prior Authorization Form

Medication Prior Authorization Form (OnabotulinumtoxinA) Dysport (abobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Xeomin (incobotulinumtoxina) Policy Number: 1042 Policy History Approve Date: 12/11/2015 Revise Dates: 7/7/2016 Next Review:

More information

Journal of Anesthesia & Pain Medicine

Journal of Anesthesia & Pain Medicine Case Report To spasm, or Not to Spasm, That is the Question Journal of Anesthesia & Pain Medicine John C McDonald BA 1 and Terence K Gray DO 1,2* 1 Mercy Pain Center, Mercy Hospital, Portland, Maine, USA

More information

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: CP.PHAR.231

Clinical Policy: IncobotulinumtoxinA (Xeomin) Reference Number: CP.PHAR.231 Clinical Policy: (Xeomin) Reference Number: CP.PHAR.231 Effective Date: 07/16 Last Review Date: 07/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better. Dystonia What are movement disorders? Movement disorders are conditions that cause involuntary body movements. With all movement disorders, abnormal signals from the brain cause patients to have trouble

More information

Dystonia. Research Programs. Treatment Options. Publications and Videos. Events and Symposiums. Patient Support. Healthcare Referral.

Dystonia. Research Programs. Treatment Options. Publications and Videos. Events and Symposiums. Patient Support. Healthcare Referral. Oral Medications Botulinum Toxin Injections Surgery Complementary Therapy Links General treatments copy Notes: Each subsection is static. Books Brochures Videos Newsletters Awareness Materials Intro Text

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Dysport) Reference Number: CP.PHAR.230 Effective Date: 07.01.16 Last Review Date: 05.18 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

Cervical dystonia is a form of abnormal movement characterized by abnormal head and neck posi8on caused by involuntary contrac8on of neck muscles.

Cervical dystonia is a form of abnormal movement characterized by abnormal head and neck posi8on caused by involuntary contrac8on of neck muscles. 1 Cervical dystonia is a form of abnormal movement characterized by abnormal head and neck posi8on caused by involuntary contrac8on of neck muscles. This may result in sustained abnormal posi8on or jerky

More information

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y Educational Objectives Improved history taking in patients with movement disorders. Develop a systematic approach to observing and describing

More information

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders Table of Contents Visit www.healthreferenceseries.com to view A Contents Guide to the Health Reference Series, a listing of more than 14,000 topics and the volumes in which they are covered. Preface...

More information

Upper Cross Syndrome: Assessment & Management in Family Practice HKDU Symposium Dec 2014

Upper Cross Syndrome: Assessment & Management in Family Practice HKDU Symposium Dec 2014 Upper Cross Syndrome: Assessment & Management in Family Practice HKDU Symposium Dec 2014 Dr. Ngai Ho Yin Allen Family Medicine Specialist PGDipMusculoskeletal Medicine MBBS(HK), DCH(London), DFM(CUHK),

More information

Tremor 101. Objectives 9/30/2015. Importance of tremors

Tremor 101. Objectives 9/30/2015. Importance of tremors Tremor 101 Umer Akbar, MD Assistant Professor, Brown University Movement Disorders Program, Rhode Island Hospital & Butler Hospital Objectives Recognize and describe the qualities of common types of tremor

More information

Dystonias. How are the dystonias classified? One way of classifying the dystonias is according to the parts of the body they affect:

Dystonias. How are the dystonias classified? One way of classifying the dystonias is according to the parts of the body they affect: Dystonias What are the dystonias? The dystonias are movement disorders in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures. The movements, which are involuntary

More information

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm Journal of Neurology, Neurosurgery, and Psychiatry 990;53:633-639 Department of Neurology, Baylor College of Medicine, Houston, Texas, United States J Jankovic K Schwartz Department of Otorhinolaryngology,

More information

Botox. Botox (onabotulinum toxin A) Description

Botox. Botox (onabotulinum toxin A) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.01 Subject: Botox Page: 1 of 8 Last Review Date: September 15, 2017 Botox Description Botox (onabotulinum

More information

Neck-2. Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology

Neck-2. Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology Neck-2 ` Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology Triangles of the neck Side of the neck Midline Lower border of mandible Line between angle of mandible and mastoid Superior nuchal

More information

Phenomenology of Movement Disorders

Phenomenology of Movement Disorders Phenomenology of Movement Disorders Raja Mehanna MD Anatomical reasoning Anatomical reasoning Phenomenological reasoning Abnormal movement Hypokinetic Hyperkinetic Ataxia Video 1 But there is a tremor!

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other ONABOTULINUMTOXINA BOTOX 04867 BRAND BOTOX COSMETIC ABOBOTULINUMTOXINA DYSPORT 36477 RIMABOTULINUMTOXINB MYOBLOC 21869 INCOBOTULINUMTOXINA XEOMIN 36687 Please use

More information

Differential Diagnosis of Hypokinetic Movement Disorders

Differential Diagnosis of Hypokinetic Movement Disorders Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease

More information

Past, Present and Future of Spasmodic Dysphonia and the use of Botulinum toxin therapy

Past, Present and Future of Spasmodic Dysphonia and the use of Botulinum toxin therapy Past, Present and Future of Spasmodic Dysphonia and the use of Botulinum toxin therapy ANDREW BLITZER, MD, DDS Professor of Clinical Otolaryngology Columbia University College Director, New York Center

More information

An Approach to Patients with Movement Disorders

An Approach to Patients with Movement Disorders An Approach to Patients with Movement Disorders Joaquim Ferreira, MD, PhD Laboratory of Clinical Pharmacology and Therapeutics Faculty of Medicine University of Lisbon EDUCATIONAL TOOLS MDS video library

More information

Dystonias Peter McAllister, MD

Dystonias Peter McAllister, MD Dystonias Peter McAllister, MD Medical Director, New England Institute for Neurology and Headache Chief Medical Officer, New England Institute for Clinical Research Clinical Assistant Professor, Neurology,

More information

Neurological disorders. Dystonia Search date September 2013 Ailsa Snaith and Derick Wade ...

Neurological disorders. Dystonia Search date September 2013 Ailsa Snaith and Derick Wade ... Search date September 213 Ailsa Snaith and Derick Wade.................................................. ABSTRACT INTRODUCTION: is usually a lifelong condition with persistent pain and disability. Focal

More information

DYSTONIA. Mysi05/Shutterstock

DYSTONIA. Mysi05/Shutterstock DYSTONIA Mysi05/Shutterstock 48 Pain-Free Living DECEMBER 2017/JANUARY 2018 W H AT I S DYSTONIA? Life impact and chronic pain treatment perspectives A patient and health coach discusses a painful neurological

More information

Ultrasonography guided dystonia & spasticity control Part I: trunk, upper extremity

Ultrasonography guided dystonia & spasticity control Part I: trunk, upper extremity Ultrasonography guided dystonia & spasticity control Part I: trunk, upper extremity Don Kyu Kim, M.D. Department of PM & R Chung Ang University College of Medicine Spasticity Vs Dystonia Velocity dependent

More information

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb)

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date:

More information

M0BCore Safety Profile

M0BCore Safety Profile M0BCore Safety Profile Active substance: Clostridium botulinum neurotoxin type A haemagglutinin complex Pharmaceutical form(s)/strength: powder for solution for injection, 300 unit and 500 unit P-RMS:

More information

Office Phone: * Cigna ID: * Date of Birth: Office Street Address: City: State: Zip:

Office Phone: * Cigna ID: * Date of Birth: Office Street Address: City: State: Zip: Phone: (800) 244-6224 Fax: (855) 840-1678 Botox (botulinum toxin type A) Notice: Please be sure to complete this form in its entirety. Missing information makes it difficult to approve requests and creates

More information

BOTULINUM TOXIN: RESEARCH ISSUES ARISING FROM PRACTICE

BOTULINUM TOXIN: RESEARCH ISSUES ARISING FROM PRACTICE % of baseline CMAP Botulinum toxin: mechanism of action BOTULINUM TOXIN: RESEARCH ISSUES ARISING FROM PRACTICE Clinical benefits of botulinum toxin (BT) injections depend primarily on the toxin's peripheral

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Xeomin) Reference Number: CP.PHAR.231 Effective Date: 07.01.16 Last Review Date: 02.19 Line of Business: Commercial, HIM, Medicaid Coding Implications Revision Log See Important Reminder

More information

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS)

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS) STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS) Karen M. Thomas D.O. Diplomate, ABPN Director of Movement Disorders Program Director of Comprehensive Parkinson s Disease Program Sentara

More information

USE OF BOTULINUM TOXIN-A IN PAIN ASSOCIATED WITH NEUROMUSCULAR DISORDERS July 2001 Executive Summary

USE OF BOTULINUM TOXIN-A IN PAIN ASSOCIATED WITH NEUROMUSCULAR DISORDERS July 2001 Executive Summary Page 1 of 34 Search Search Health Technology Advisory Committee Home Publications Links Search USE OF BOTULINUM TOXIN-A IN PAIN ASSOCIATED WITH NEUROMUSCULAR DISORDERS July 2001 Executive Summary The strains

More information

Headache and Migraine Treatment

Headache and Migraine Treatment Many of us think of Botox primarily as a cosmetic treatment for lines and wrinkles on the face, but the botulinum toxin that Botox is derived from has a long history of medically therapeutic uses. In fact,

More information

MYOBLOC and Cervical Dystonia A Patient s Guide

MYOBLOC and Cervical Dystonia A Patient s Guide MYOBLOC and Cervical Dystonia A Patient s Guide MYOBLOC (rimabotulinumtoxinb) Injection is indicated for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position

More information

Treatment of dystonia

Treatment of dystonia Review Treatment of dystonia Roongroj Bhidayasiri and Daniel Tarsy CONTENTS Pharmacological therapy Anticholinergic drugs Antidopaminergic drugs Other pharmacological agents Botulinum toxin therapy Surgical

More information

Medication Prior Authorization Form

Medication Prior Authorization Form (OnabotulinumtoxinA) Dysport (abobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Xeomin (incobotulinumtoxina) Policy Number: 1042 Policy History Approve Date: 12/11/2015 Revise Dates: 07/07/2017 Next Review:

More information

Prior Authorization Update: Botulinum Toxins

Prior Authorization Update: Botulinum Toxins Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Botulinum Toxin Therapy Billing & Coding Update 2016

Botulinum Toxin Therapy Billing & Coding Update 2016 Botulinum Toxin Therapy Billing & Coding Update 2016 Martin Taylor, DO, PhD Neurology / OrthoNeuro Clinical Associate Professor, Neurology Ohio University College of Osteopathic Medicine Columbus, OH Disclosures

More information

Clare Gaduzo BSc RMN Registered Aesthetics Practitioner (qualified with Medics Direct)

Clare Gaduzo BSc RMN Registered Aesthetics Practitioner (qualified with Medics Direct) Clare Gaduzo BSc RMN Registered Aesthetics Practitioner (qualified with Medics Direct) 07935567067 cjg.aesthetics@yahoo.co.uk www.cjgaesthetics.co.uk http://www.facebook.com/cjgaesthetics @CJGAesthetics

More information

Bone Practical. Labs Muscle Labs. Final Practical. Divisions of the Muscular System. Quiz format

Bone Practical. Labs Muscle Labs. Final Practical. Divisions of the Muscular System. Quiz format Bone Practical Labs 17 + 18 Muscles Wed 7/11 @ 8am 40 50 stations About half axial, half appendicular bones Disarticulated bones: Skulls, partial skulls, vertebrae, ribs, skeletons, arm bones, leg bones,

More information

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London An approach to movement disorders Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London Neurology Diagnosis Two main questions: What parts of the nervous

More information

MEDICATION GUIDE BOTOX BOTOX Cosmetic (Boe-tox) (onabotulinumtoxina) for Injection

MEDICATION GUIDE BOTOX BOTOX Cosmetic (Boe-tox) (onabotulinumtoxina) for Injection 17.2 Ability to Operate Machinery or Vehicles Advise patients that if loss of strength, muscle weakness, blurred vision, or drooping eyelids occur, they should avoid driving a car or engaging in other

More information

Disclosures 2/13/2015. Case: Case (cont)

Disclosures 2/13/2015. Case: Case (cont) Disclosures Recent Advances in Neurology Case Presentation Educational grant support: Medtronic Inc., Merz, Inc., Allergan, Inc. Clinical trial support: Ceregene Inc., MRI Interventions Inc., St. Jude

More information

Treating Adults with Cervical Dystonia

Treating Adults with Cervical Dystonia Treating Adults with Cervical Dystonia Learn more about Dysport Talk to your doctor about Dysport and find out if it is right for you. What is Dysport? Dysport is a prescription medicine that is injected

More information

BOTULINUM TOXIN POLICY TO INCLUDE:

BOTULINUM TOXIN POLICY TO INCLUDE: BOTULINUM TOXIN POLICY TO INCLUDE: Blepharospasm in adults, Hemi facial spasm in adults, spasmodic torticollis (cervical dystonia), focal spasticity treatment of dynamic equinus foot deformity, focal spasticity

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Botulinum Toxins Reference Number: TCHP.PHAR.1812 Effective Date: 07.01.2018 Last Review Date: 04.13.2018 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the

More information

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb)

Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Botox (onabotulinumtoxina) Dysport (abobotulinumtoxina) Xeomin (incobotulinumtoxina) Myobloc (rimabotulinumtoxinb) Line(s) of Business: HMO; PPO; QUEST Integration Medicare Advantage Original Effective

More information

Disorders of language and speech. Samuel Komoly MD PhD DHAS Professor and Chairman Department of Neurology

Disorders of language and speech. Samuel Komoly MD PhD DHAS Professor and Chairman Department of Neurology Disorders of language and speech Samuel Komoly MD PhD DHAS Professor and Chairman Department of Neurology http://neurology.pote.hu major categories disorders of language and speech cortical types aphasias

More information

Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB

Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB 2.11.16 Disclosures I have no relevant conflicts or potential conflicts to disclose regarding

More information

Botox. Botox (onabotulinum toxin A) Description

Botox. Botox (onabotulinum toxin A) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.01 Subject: Botox Page: 1 of 10 Last Review Date: November 30, 2018 Botox Description Botox (onabotulinum

More information

Quantitative Assessment of Botulinum Toxin Treatment in 43 Patients with Head Tremor

Quantitative Assessment of Botulinum Toxin Treatment in 43 Patients with Head Tremor ~~~~~ ~ ~ Movement Disorder& Vol. 12, NO. 5, 1997, pp 122-126 0 1997 Movemcnt Disorder Society Quantitative Assessment of Botulinum Toxin Treatment in 43 Patients with Head Tremor "tjorg Wissel, "Florian

More information

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)? Pharmacy Prior Authorization AETA BETTER HEALTH MICHIGA Botulinum Toxins (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign

More information

Tremor What is tremor? What causes tremor? What are the characteristics of tremor? What are the different categories of tremor?

Tremor What is tremor? What causes tremor? What are the characteristics of tremor? What are the different categories of tremor? Tremor What is tremor? Tremor is an unintentional, somewhat rhythmic, muscle movement involving to-and-fro movements (oscillations) of one or more parts of the body. It is the most common of all involuntary

More information

R AT I N G S C A L E S. CODING/BILLING.

R AT I N G S C A L E S. CODING/BILLING. Paieška Paieška Paieška Cpt code for botox injection into the splenius capitis Cpt code for botox injection into the splenius capitis > > Correct coding using current procedural terminology (CPT) and International.

More information

Botox , The Patient Education Institute, Inc. rxf60101 Last reviewed: 01/11/2018 1

Botox , The Patient Education Institute, Inc.  rxf60101 Last reviewed: 01/11/2018 1 Botox Introduction Botox is a well known brand name for a medicinal form of a toxin, or poison. When injected in small doses into specific muscles, Botox doesn't poison you. Instead, it acts as a muscle

More information

Botulinum toxins: abobotulinumtoxina (Dysport ), incobotulinumtoxina (Xeomin ), onabotulinumtoxina (Botox ), & rimabotulinumtoxinb (Myobloc )

Botulinum toxins: abobotulinumtoxina (Dysport ), incobotulinumtoxina (Xeomin ), onabotulinumtoxina (Botox ), & rimabotulinumtoxinb (Myobloc ) Botulinum toxins: abobotulinumtoxina (Dysport ), incobotulinumtoxina (Xeomin ), onabotulinumtoxina (Botox ), & rimabotulinumtoxinb (Myobloc ) These services may or may not be covered by your HealthPartners

More information

THE MEDICAL AND SURGICAL TREATMENT OF DYSTONIA

THE MEDICAL AND SURGICAL TREATMENT OF DYSTONIA THE MEDICAL AND SURGICAL TREATMENT OF DYSTONIA Samuel Frank, MD Beth Israel Deaconess Medical Center Boston, MA Dystonia may present as an isolated disorder or as part of another disease process. The clinical

More information

The Neck the lower margin of the mandible above the suprasternal notch and the upper border of the clavicle

The Neck the lower margin of the mandible above the suprasternal notch and the upper border of the clavicle The Neck is the region of the body that lies between the lower margin of the mandible above and the suprasternal notch and the upper border of the clavicle below Nerves of the neck Cervical Plexus Is formed

More information

Neuromuscular Blocking Agents

Neuromuscular Blocking Agents Neuromuscular Blocking Agents DRUG POLICY This Prior Authorization request will be reviewed for medical necessity only. Benefits are subject to the terms and conditions of the patient s contract. Please

More information

Parkinson s Disease. Sirilak yimcharoen

Parkinson s Disease. Sirilak yimcharoen Parkinson s Disease Sirilak yimcharoen EPIDEMIOLOGY ~1% of people over 55 years Age range 35 85 years peak age of onset is in the early 60s ~5% of cases characterized by an earlier age of onset (typically

More information

Moving fast or moving slow: an overview of Movement Disorders

Moving fast or moving slow: an overview of Movement Disorders Moving fast or moving slow: an overview of Movement Disorders Mini Medical School October 25, 2018 Heather Rigby, MD, FRCPC 2014 MFMER slide-1 2014 MFMER slide-2 Basal Ganglia Dysfunction - Movement Disorders

More information

National Consensus Statement for Diagnosis and Treatment of Hyperkinetic Motor Disorders

National Consensus Statement for Diagnosis and Treatment of Hyperkinetic Motor Disorders National Consensus Statement for Diagnosis and Treatment of Hyperkinetic Motor Disorders Edited by Acad. Prof. Dr. Ivan Milanov, MD; Assoc. Prof. Dr. Dimitar Georgiev, MD; Dr. Vesselina Grozeva, MD and

More information

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department Hyperkinetic movement disorders Increase in muscle movements causing involuntary motion Tremor Dystonia

More information

CHOREA AND DYSTONIA. Joohi Jimenez-Shahed, MD Baylor College of Medicine Houston, TX

CHOREA AND DYSTONIA. Joohi Jimenez-Shahed, MD Baylor College of Medicine Houston, TX CHOREA AND DYSTONIA Joohi Jimenez-Shahed, MD Baylor College of Medicine Houston, TX INTRODUCTION The key to successful differential diagnosis and treatment of patients with movement disorders is successful

More information

Prescribing issues in spasticity and dystonia. Professor Rajat Gupta Consultant Paediatric Neurologist Birmingham Children s Hospital

Prescribing issues in spasticity and dystonia. Professor Rajat Gupta Consultant Paediatric Neurologist Birmingham Children s Hospital Prescribing issues in spasticity and dystonia Professor Rajat Gupta Consultant Paediatric Neurologist Birmingham Children s Hospital Cerebral palsy is common, affecting about 2-3 per 1000 children Surveillance

More information

CLINICAL MANIFESTATIONS AND CLASSIFICATION OF DYSTONIA

CLINICAL MANIFESTATIONS AND CLASSIFICATION OF DYSTONIA CLINICAL MANIFESTATIONS AND CLASSIFICATION OF DYSTONIA Daniel Tarsy, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA The term dystonia was coined by Oppenheim in 1911 for a disorder

More information

Parkinson's Disease Center and Movement Disorders Clinic

Parkinson's Disease Center and Movement Disorders Clinic Parkinson's Disease Center and Movement Disorders Clinic 7200 Cambridge Street, 9th Floor, Suite 9A Houston, Texas 77030 713-798-2273 phone www.jankovic.org Botulinum Toxin Botulinum toxin (BTX) has been

More information

Pallidal Deep Brain Stimulation

Pallidal Deep Brain Stimulation Pallidal Deep Brain Stimulation Treatment for Dystonia Dystonia Dystonia is a neurological disorder characterized by involuntary muscle contractions resulting in abnormal postures. These movements may

More information

Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else?

Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else? Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else? California Association of Nurse Practitioners Monterey, March 22, 2013 Julie Sprague-McRae, MS, RN, PPCNP-BC Ruth

More information

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Dysport. It does not contain all

More information

Botulinum Toxins. Length of Authorization: From 90 days to 12 months

Botulinum Toxins. Length of Authorization: From 90 days to 12 months Botulinum Toxins Goal(s): Approve botulinum toxins for funded OHP conditions supported by evidence of benefit (eg, dystonia or spasticity associated with certain neurological diseases). Require positive

More information

Spasmodic dysphonia Symptoms

Spasmodic dysphonia Symptoms Spasmodic dysphonia Spasmodic dysphonia belongs to a family of neurological disorders called dystonias. A dystonia is a movement disorder that causes muscles to contract and spasm involuntarily. Dystonias

More information

Posterior Triangle of the Neck By Prof. Dr. Muhammad Imran Qureshi

Posterior Triangle of the Neck By Prof. Dr. Muhammad Imran Qureshi Posterior Triangle of the Neck By Prof. Dr. Muhammad Imran Qureshi For the purpose of anatomical description the neck is sub divided into two major triangles, the Anterior and the Posterior by muscle bellies

More information

Articles Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis

Articles Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis Freely available online Articles Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis Daniel Martinez-Ramirez 1, Juan C. Giugni 1, Erin Hastings 1,

More information

82a Orthopedic Massage! Introduction - Thoracic Outlet"

82a Orthopedic Massage! Introduction - Thoracic Outlet 82a Orthopedic Massage! Introduction - Thoracic Outlet" 82a Orthopedic Massage! Introduction - Thoracic Outlet! Class Outline" 5 minutes" "Attendance, Breath of Arrival, and Reminders " 10 minutes "Lecture:"

More information

of common terms Amplitude Resting Position Essential Tremor (ET) Glossary

of common terms Amplitude Resting Position Essential Tremor (ET) Glossary Essential Tremor (ET) Glossary of common terms Because knowledge is essential to making informed choices, we ve developed this glossary to help ET patients, their loved ones, and caregivers better understand

More information

BOTOX (onabotulinumtoxina) for Therapeutic Use

BOTOX (onabotulinumtoxina) for Therapeutic Use BOTOX (onabotulinumtoxina) for Therapeutic Use BOTOX (onabotulinumtoxina) & BOTOX Cosmetic (onabotulinumtoxina) Important Information IMPORTANT SAFETY INFORMATION BOTOX and BOTOX Cosmetic may cause serious

More information

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex)

DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) DYSPORT (Clostridium botulinum type A toxin-haemagglutinin complex) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Dysport. It does not contain all

More information